Wen‐Feng Gong

1.5k total citations
29 papers, 1.1k citations indexed

About

Wen‐Feng Gong is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Wen‐Feng Gong has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 12 papers in Epidemiology and 8 papers in Oncology. Recurrent topics in Wen‐Feng Gong's work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver Disease Diagnosis and Treatment (12 papers) and Cancer Mechanisms and Therapy (7 papers). Wen‐Feng Gong is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver Disease Diagnosis and Treatment (12 papers) and Cancer Mechanisms and Therapy (7 papers). Wen‐Feng Gong collaborates with scholars based in China and United States. Wen‐Feng Gong's co-authors include Jian‐Hong Zhong, Bang‐De Xiang, Liang Ma, Le‐Qun Li, Ke Yang, Tao Peng, Gui‐Sheng Xie, Xinping Ye, Le‐Qun Li and Feixiang Wu and has published in prestigious journals such as PLoS ONE, Cancer Research and Annals of Surgery.

In The Last Decade

Wen‐Feng Gong

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Feng Gong China 14 800 436 324 316 277 29 1.1k
Li‐Jian Liang China 17 535 0.7× 292 0.7× 474 1.5× 309 1.0× 250 0.9× 33 986
Fabrício Henrique Pereira De Souza United States 6 648 0.8× 289 0.7× 218 0.7× 171 0.5× 225 0.8× 8 950
Hirokazu Chishina Japan 18 900 1.1× 378 0.9× 225 0.7× 163 0.5× 199 0.7× 44 1.1k
Jie Mei China 18 525 0.7× 212 0.5× 263 0.8× 243 0.8× 211 0.8× 51 898
A. Baldan Italy 7 647 0.8× 306 0.7× 137 0.4× 191 0.6× 162 0.6× 10 862
Bolorsukh Gansukh United States 6 421 0.5× 246 0.6× 261 0.8× 200 0.6× 156 0.6× 8 847
Jong Young Choi South Korea 18 899 1.1× 397 0.9× 171 0.5× 178 0.6× 315 1.1× 33 1.1k
Minke He China 14 799 1.0× 230 0.5× 234 0.7× 143 0.5× 313 1.1× 41 1.1k
Jijin Yang China 10 686 0.9× 316 0.7× 146 0.5× 145 0.5× 147 0.5× 23 862
Miho Kanda Japan 9 567 0.7× 200 0.5× 187 0.6× 139 0.4× 282 1.0× 15 759

Countries citing papers authored by Wen‐Feng Gong

Since Specialization
Citations

This map shows the geographic impact of Wen‐Feng Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Feng Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Feng Gong more than expected).

Fields of papers citing papers by Wen‐Feng Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Feng Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Feng Gong. The network helps show where Wen‐Feng Gong may publish in the future.

Co-authorship network of co-authors of Wen‐Feng Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Feng Gong. A scholar is included among the top collaborators of Wen‐Feng Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Feng Gong. Wen‐Feng Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Yanji, Wen‐Feng Gong, Yingchun Liu, et al.. (2024). Serum CHI3L1 Levels Predict Overall Survival of Hepatocellular Carcinoma Patients after Hepatectomy. Journal of Cancer. 15(19). 6315–6325. 3 indexed citations
2.
Xiang, Bang‐De, et al.. (2023). Is hepatectomy feasible for hepatocellular carcinoma patients with clinically significant portal hypertension and beyond the Milan criteria?. European Journal of Surgical Oncology. 49(11). 107073–107073. 1 indexed citations
3.
Liu, Yingchun, Zihan Zhou, Runwei Li, et al.. (2022). Prognostic Value of Aspartate Transaminase/Alanine Transaminase Ratio in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Undergoing Hepatectomy. Frontiers in Oncology. 12. 876900–876900. 15 indexed citations
4.
Su, Ting‐Shi, Wen‐Feng Gong, Jian‐Hong Zhong, et al.. (2022). Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial. Hepatology International. 16(5). 1179–1187. 24 indexed citations
5.
Ma, Liang, Feixiang Wu, Yuanyuan Chen, et al.. (2021). S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma. Hepatology International. 15(1). 114–126. 22 indexed citations
6.
Qi, Lu‐Nan, Liang Ma, Yuanyuan Chen, et al.. (2019). Outcomes of anatomical versus non-anatomical resection for hepatocellular carcinoma according to circulating tumour-cell status. Annals of Medicine. 52(1-2). 21–31. 24 indexed citations
7.
Qi, Lu‐Nan, Bang‐De Xiang, Feixiang Wu, et al.. (2018). Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma. Cancer Research. 78(16). 4731–4744. 226 indexed citations
8.
Ye, Jiazhou, Zhibo Xie, Tao Bai, et al.. (2018). Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection. Oncology Letters. 16(4). 4937–4944. 8 indexed citations
9.
Zhong, Jian‐Hong, Linghui Pan, Yanyan Wang, et al.. (2017). Optimizing stage of single large hepatocellular carcinoma. Medicine. 96(15). e6608–e6608. 13 indexed citations
10.
11.
Gong, Wen‐Feng, et al.. (2016). Influence of preoperative antiviral therapy on HBV reactivation and liver function after liver resection in HBV-DNA-negative hepatocellular carcinoma patients. 43(15). 673. 1 indexed citations
12.
Ye, Jiazhou, Zhibo Xie, Tao Bai, et al.. (2016). Postoperative adjuvant transarterial chemoembolization after curative resection reduces early recurrence of hepatocellular carcinoma. Zhonghua gan-dan waike zazhi. 22(4). 217–222. 1 indexed citations
13.
Zhong, Jian‐Hong, Yang Ke, Shao‐Liang Zhu, et al.. (2016). Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection. OncoTargets and Therapy. Volume 9. 6897–6907. 10 indexed citations
14.
15.
Liu, Lei, Qishun Zhang, Linghui Pan, et al.. (2015). Subclassification of patients with solitary hepatocellular carcinoma based on post-hepatectomy survival: a large retrospective study. Tumor Biology. 37(4). 5327–5335. 7 indexed citations
16.
Xie, Zhibo, Xiaobo Wang, Yuchong Peng, et al.. (2014). Systematic review comparing the safety and efficacy of conventional and drug‐eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma. Hepatology Research. 45(2). 190–200. 71 indexed citations
17.
Gong, Wen‐Feng, Jian‐Hong Zhong, Bang‐De Xiang, et al.. (2013). Single Nucleotide Polymorphism 8q24 rs13281615 and Risk of Breast Cancer: Meta-Analysis of More than 100,000 Cases. PLoS ONE. 8(4). e60108–e60108. 13 indexed citations
18.
Zhong, Jian‐Hong, Ke Yang, Wen‐Feng Gong, et al.. (2013). Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma. Annals of Surgery. 260(2). 329–340. 347 indexed citations
19.
Zhong, Jian‐Hong, Bang‐De Xiang, Wen‐Feng Gong, et al.. (2013). Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization. PLoS ONE. 8(7). e68193–e68193. 123 indexed citations
20.
Zhong, Jian‐Hong, Xue‐Mei You, Wen‐Feng Gong, et al.. (2012). Epidermal Growth Factor Gene Polymorphism and Risk of Hepatocellular Carcinoma: A Meta-Analysis. PLoS ONE. 7(3). e32159–e32159. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li‐Jian Liang Breakdown of academic impact, for papers by Fabrício Henrique Pereira De Souza Breakdown of academic impact, for papers by Hirokazu Chishina Breakdown of academic impact, for papers by Jie Mei Breakdown of academic impact, for papers by A. Baldan Breakdown of academic impact, for papers by Bolorsukh Gansukh Breakdown of academic impact, for papers by Jong Young Choi Breakdown of academic impact, for papers by Minke He Breakdown of academic impact, for papers by Jijin Yang Breakdown of academic impact, for papers by Miho Kanda
Rankless by CCL
2026